Aortic stenosis trials in China
42 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleVericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression
- Where
- Chengdu
- Age
- 35 years to 80 years
- People
- 238
- Run by
- West China Hospital
See details and how to joinNCT07715279 - Phase 3Taking peopleStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Beijing
- Age
- 2 years to 11 years
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006 - No phaseTaking peopleSapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
- Where
- Beijing, Chengdu, Shanghai, Xi'an
- Age
- 50 years to 70 years
- People
- 450
- Run by
- Xijing Hospital
See details and how to joinNCT06830499 - No phaseNot yet taking people in ChinaActive Post-Market Surveillance of Innovative Devices for Valvular Heart Disease
- Where
- Beijing
- Age
- 18 years and over
- People
- 5,500
- Run by
- Beijing Anzhen Hospital
See details and how to joinNCT07605624 - Phase 3Taking peopleStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- Beijing, Shanghai
- Age
- 6 years to 11 years
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019 - No phaseNot yet taking people in ChinaA Prospective, Multicenter, Observational Study Evaluating Safety and Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Replacement for Type-0 Bicuspid Aortic Valve Stenosis Patients in China
- Where
- Beijing
- Age
- 50 years and over
- People
- 170
- Run by
- Chinese Academy of Medical Sciences, Fuwai Hospital
See details and how to joinNCT07450196 - Phase 4Not yet taking people in ChinaEcho-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis(ECHO-TAVR)
- Where
- Beijing
- Age
- 65 years and over
- People
- 212
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT07317804 - No phaseTaking peopleCLEAR-AS: CT-FFR-Guided Revascularization in Patients With Severe Aortic Stenosis
- Where
- Kunming
- Age
- 18 years and over
- People
- 300
- Run by
- Yan'an Affiliated Hospital of Kunming Medical University
See details and how to joinNCT07469371 - Phase 3Not yet taking people in ChinaPCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis
- Where
- Beijing
- Age
- 18 years to 85 years
- People
- 160
- Run by
- Beijing Anzhen Hospital
See details and how to joinNCT07256197 - No phaseTaking peopleTransaxillary TAVR With Solely Echocardiography Guidance
- Where
- Beijing
- People
- 20
- Run by
- Chinese Academy of Medical Sciences, Fuwai Hospital
See details and how to joinNCT07035847 - No phaseTaking peopleSafety and Efficacy of the RENATUS® Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis
- Where
- Beijing
- Age
- 60 years to 100 years
- People
- 800
- Run by
- Beijing Balance Medical Technology Co., Ltd
See details and how to joinNCT07414342 - No phaseTaking peopleNoninvasive Real-Time Arterial Waveform Monitoring for Cardiovascular Disease Assessment
- Where
- Hefei
- Age
- 18 years to 80 years
- People
- 15
- Run by
- Anhui Provincial Cancer Hospital
See details and how to joinNCT07350629 - No phaseTaking peopleA Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis
- Where
- Shanghai
- Age
- 18 years and over
- People
- 25
- Run by
- RenJi Hospital
See details and how to joinNCT07335900 - No phaseTaking peopleCohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
- Where
- Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Hangzhou, Kunming, Qingdao, Shanghai, Shenyang, Ürümqi, Wuhan, Xi'an
- Age
- 18 years and over
- People
- 10,000
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07267117 - No phaseEnrolling by invitationTAVR vs. SAVR Study of VitaFlow Liberty® for Severe BAV Stenosis
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 452
- Run by
- Shanghai MicroPort CardioFlow Medtech Co., Ltd.
See details and how to joinNCT06597188 - No phaseTaking peopleProspective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions
- Where
- Shanghai
- Age
- 18 years and over
- People
- 232
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07145463 - No phaseNot yet taking people in ChinaA Prospective, Multicenter, Observational Study of the Safety and Efficacy of Emergency Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis
- Where
- Jinan
- Age
- 70 years and over
- People
- 35
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07108478 - No phaseTaking peopleEarly Feasibility Study of Surgical Implantation of a Polymer Prosthetic Mitral and Aortic Valve
- Where
- Shanghai
- Age
- 50 years and over
- People
- 10
- Run by
- Mitrassist Lifesciences Limited Co., Ltd.
See details and how to joinNCT07097740 - No phaseEnrolling by invitationA Clinical Study on the Use of the Sentinel Cerebral Protection Device During TAVR for the Prevention of Procedure-Related Stroke
- Where
- Beijing
- Age
- 18 years and over
- People
- 200
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT07045233 - No phaseEnrolling by invitationVideodensitometric Angiographic Assessment of AR in the Cath-lab for Intraprocedural Guidance of TAVI in CHINA
- Where
- Shanghai, Xi'an
- Age
- 18 years and over
- People
- 320
- Run by
- Xijing Hospital
See details and how to joinNCT06891079 - No phaseTaking peopleChanges of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
- Where
- Beijing
- People
- 480
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT05739253 - No phaseTaking peopleA Study of Chinese Congenital Bicuspid Aortic Valve
- Where
- Shanghai
- Age
- 14 years to 60 years
- People
- 500
- Run by
- Ruijin Hospital
See details and how to joinNCT06802016 - No phaseTaking peopleAn Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease
- Where
- Beijing
- Age
- 1 day to 28 days
- People
- 10,000
- Run by
- Beijing Anzhen Hospital
See details and how to joinNCT06768008 - No phaseTaking peopleEfficacy of Self-expandable and Balloon-expandable Valves in Patients With Ascending Aortic Dilation
- Where
- Beijing, Kunming, Shenzhen
- Age
- 65 years and over
- People
- 100
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT06743568 - No phaseEnrolling by invitationEvaluating the Safety and Efficacy of Prosthetic Polymer Heart Valves for the Treatment of Aortic Valve Disease
- Where
- Shanghai
- Age
- 18 years and over
- People
- 10
- Run by
- Suzhou Hearthill Medical Technology Co.,LTD
See details and how to joinNCT06518681